Tumour immunotherapy against MUC1 expressing tumours using mannan MUC1

被引:0
|
作者
Apostolopoulos, V
Pietersz, GA
Acres, B
Osinski, C
Thynne, G
Xing, PX
Karanikas, V
Vaughan, HA
Hwang, L
Popovski, V
Lees, C
Ong, CS
McKenzie, IFC
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:315 / 320
页数:6
相关论文
共 50 条
  • [1] MUC1 immunotherapy
    Beatson, Richard E.
    Taylor-Papadimitriou, Joyce
    Burchell, Joy M.
    [J]. IMMUNOTHERAPY, 2010, 2 (03) : 305 - 327
  • [2] Immunotherapy with mannan-MUC1 and IL-12 in MUC1 transgenic mice
    Lees, CJ
    Apostolopoulos, V
    Acres, B
    Ramshaw, I
    Ramsay, A
    Ong, CS
    McKenzie, IFC
    [J]. VACCINE, 2000, 19 (2-3) : 158 - 162
  • [3] Inhibiting MUC1 a/b chain interaction mediates cytotoxicity of cells expressing MUC1: The MUC1 dyad oncoprotein as a functional target
    Karmely, M.
    Rubinstein, D. B.
    Pichinuk, E.
    Ziv, R.
    Benhar, I.
    Feng, N.
    Wreschner, D. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Latest developments in MUC1 immunotherapy
    Taylor-Papadimitriou, Joyce
    Burchell, Joy M.
    Graham, Rosalind
    Beatson, Richard
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2018, 46 : 659 - 668
  • [5] MUC1 immunotherapy is here to stay
    Kimura, Takashi
    Finn, Olivera J.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (01) : 35 - 49
  • [6] MUC1 as a target antigen for cancer immunotherapy
    Acres, B
    Limacher, JM
    [J]. EXPERT REVIEW OF VACCINES, 2005, 4 (04) : 493 - 502
  • [7] Molecular Mimics of the Tumour Antigen MUC1
    James, Tharappel C.
    Bond, Ursula
    [J]. PLOS ONE, 2012, 7 (11):
  • [8] MUC1 and cancer
    Taylor-Papadimitriou, J
    Burchell, J
    Miles, DW
    Dalziel, M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1999, 1455 (2-3): : 301 - 313
  • [9] MUC1 expressing tumor growth was retarded after human mucin 1 (MUC1) plasmid DNA immunization
    Son, Hye-Youn
    Jeong, Hwan-Kyu
    Apostolopoulos, Vasso
    Kim, Chul-Woo
    [J]. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2022, 36
  • [10] Immunization with a Synthetic Human MUC1 Glycopeptide Vaccine against Tumor-Associated MUC1 Breaks Tolerance in Human MUC1 Transgenic Mice
    Stergiou, Natascha
    Glaffig, Markus
    Jonuleit, Helmut
    Schmitt, Edgar
    Kunz, Horst
    [J]. CHEMMEDCHEM, 2017, 12 (17) : 1424 - 1428